These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15662077)

  • 21. Hyperkalemia in outpatients using angiotensin-converting enzyme inhibitors. How much should we worry?
    Reardon LC; Macpherson DS
    Arch Intern Med; 1998 Jan; 158(1):26-32. PubMed ID: 9437375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cough induced by losartan with resolution after substitution with enalapril.
    Dashti-Khavidaki S; Faghihi T; Ahmadi F; Khalili H
    Clin Ther; 2008 Mar; 30(3):548-51. PubMed ID: 18405793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Reversible impairment of renal function during treatment with lisinopril, an ACE-inhibitor (case report)].
    Lakusić N; Mahović D; Ciglenecki N; Kurnik R; Cerovec D; Majsec M
    Lijec Vjesn; 2001; 123(9-10):245-8. PubMed ID: 11845579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid life-threatening hyperkalemia after addition of amiloride HCl/hydrochlorothiazide to angiotensin-converting enzyme inhibitor therapy.
    Chiu TF; Bullard MJ; Chen JC; Liaw SJ; Ng CJ
    Ann Emerg Med; 1997 Nov; 30(5):612-5. PubMed ID: 9360571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intermittent visceral edema induced by long-term enalapril administration.
    Orr KK; Myers JR
    Ann Pharmacother; 2004 May; 38(5):825-7. PubMed ID: 15039478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adverse effects of combination angiotensin II receptor blockers plus angiotensin-converting enzyme inhibitors for left ventricular dysfunction: a quantitative review of data from randomized clinical trials.
    Phillips CO; Kashani A; Ko DK; Francis G; Krumholz HM
    Arch Intern Med; 2007 Oct; 167(18):1930-6. PubMed ID: 17923591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does concurrent renin-angiotensin-aldosterone blockade in (older) chronic kidney disease patients play a role in the acute renal failure epidemic in US hospitalized patients?--Three cases of severe acute renal failure encountered in a northwestern Wisconsin Nephrology practice.
    Onuigbo MA
    Hemodial Int; 2009 Oct; 13 Suppl 1():S24-9. PubMed ID: 19775421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Fetal angiotensin converting enzyme (ACE) inhibition renal failure].
    Muto R; Ohashi H
    Ryoikibetsu Shokogun Shirizu; 2001; (33):678-9. PubMed ID: 11462629
    [No Abstract]   [Full Text] [Related]  

  • 29. Acute renal failure associated with use of angiotensin converting enzyme inhibitor--a report of two children with Down's syndrome.
    Krishna EV; Mehta AV; Subrahmanyam AB; Wattad AA
    J Tenn Med Assoc; 1996 Jan; 89(1):5-7. PubMed ID: 8544450
    [No Abstract]   [Full Text] [Related]  

  • 30. Spironolactone + ace inhibitor or sartan: risk of hyperkalaemia.
    Prescrire Int; 2004 Apr; 13(70):58. PubMed ID: 15148978
    [No Abstract]   [Full Text] [Related]  

  • 31. [Ineffective atrial pacing and cardiac arrest in a 80-year old woman with hyperkalemia].
    Lelakowski J; Czunko A; Majewski J; Pasowicz M; Małecka B; Bednarek J
    Pol Merkur Lekarski; 2005 May; 18(107):566-7. PubMed ID: 16161957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does the combination of aprotinin and angiotensin-converting enzyme inhibitor cause renal failure after cardiac surgery?
    Kincaid EH; Ashburn DA; Hoyle JR; Reichert MG; Hammon JW; Kon ND
    Ann Thorac Surg; 2005 Oct; 80(4):1388-93; discussion 1393. PubMed ID: 16181876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fatal hyperkalemia related to combined therapy with a COX-2 inhibitor, ACE inhibitor and potassium rich diet.
    Hay E; Derazon H; Bukish N; Katz L; Kruglyakov I; Armoni M
    J Emerg Med; 2002 May; 22(4):349-52. PubMed ID: 12113843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug-induced hyperkalaemia is frequent.
    Prescrire Int; 2007 Feb; 16(87):16. PubMed ID: 17323523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A propensity score analysis of the impact of angiotensin-converting enzyme inhibitors on long-term survival of older adults with heart failure and perceived contraindications.
    Ahmed A; Centor RM; Weaver MT; Perry GJ
    Am Heart J; 2005 Apr; 149(4):737-43. PubMed ID: 15990761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Anaphylactoid reactions with the use of ST-AN69 dialysers in patients taking ACE inhibitors].
    Roux VD; Plaisance M
    Nephrol Ther; 2008 Oct; 4(5):335-8. PubMed ID: 18514054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inducing hyperkalemia by converting enzyme inhibitors and heparin.
    Durand D; Ader JL; Rey JP; Tran-Van T; Lloveras JJ; Bernadet P; Suc JM
    Kidney Int Suppl; 1988 Sep; 25():S196-7. PubMed ID: 3184611
    [No Abstract]   [Full Text] [Related]  

  • 38. Severe hyperkalaemia due to the concomitant use of salt substitutes and ACE inhibitors in hypertension: a potentially life threatening interaction.
    Ray K; Dorman S; Watson R
    J Hum Hypertens; 1999 Oct; 13(10):717-20. PubMed ID: 10516744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of recurrent angiotensin converting enzyme inhibitor-induced angioedema.
    Roberts DS; Mahoney EJ; Hutchinson CT; Aliphas A; Grundfast KM
    Laryngoscope; 2008 Dec; 118(12):2115-20. PubMed ID: 19029862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Severe hyperkalaemia induced by trimethoprim in combination with an angiotensin-converting enzyme inhibitor in a patient with transplanted lungs.
    Jolobe OM
    J Intern Med; 1997 Jul; 242(1):88-9. PubMed ID: 9260574
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.